Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Equity Average (2022 - 2025)

Historic Equity Average for Indivior Pharmaceuticals (INDV) over the last 2 years, with Q3 2025 value amounting to -$232.0 million.

  • Indivior Pharmaceuticals' Equity Average changed N/A to -$232.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$232.0 million, marking a year-over-year change of. This contributed to the annual value of -$260.5 million for FY2024, which is 29172.93% down from last year.
  • Latest data reveals that Indivior Pharmaceuticals reported Equity Average of -$232.0 million as of Q3 2025.
  • Indivior Pharmaceuticals' 5-year Equity Average high stood at -$87.0 million for Q1 2024, and its period low was -$311.0 million during Q1 2025.